Jackson Laboratory

The Jackson Laboratory was founded in Bar Harbor, Maine in 1929 by former University of Maine and University of Michigan president C. C. Little under the name Roscoe B. Jackson Memorial Laboratory. The Jackson Laboratory is an independent, nonprofit biomedical research institution, dedicated to contributing to a future of better health care based on the unique genetic makeup of each individual. With more than 1,400 employees in Bar Harbor, Maine, and Sacramento, California, the Laboratory's mission is to discover the genetic basis for preventing, treating and curing human diseases, and to enable research and education for the global biomedical community. The institution is a National Cancer Institute-designated Cancer Center and has NIH centers of excellence in aging and systems genetics. The Laboratory is also the world's source for more than 5,000 strains of genetically defined mice, is home of the mouse genome database and is an international hub for scientific courses, conferences, training and education.

Website
http://www.jax.org/
Wikipedia
http://en.wikipedia.org/wiki/Jackson_Laboratory

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Medical research

Team discovers lung regeneration mechanism

A research team led by Jackson Laboratory Professors Frank McKeon, Ph.D., and Wa Xian, Ph.D., reports on the role of certain lung stem cells in regenerating lungs damaged by disease.

Diseases, Conditions, Syndromes

The many manifestations of long COVID

Over the past three years, it has become clear that, for many people, the effects of SARS-CoV-2 infection persist long after an initial case of COVID-19 wanes.

Ophthalmology

Vitamin B3 prevents glaucoma in laboratory mice

In mice genetically predisposed to glaucoma, vitamin B3 added to drinking water is effective at preventing the disease, a research team led by Jackson Laboratory Professor and Howard Hughes Medical Investigator Simon W.M. ...

Diabetes

Researchers block B-cell AID, prevent diabetes in NOD mice

Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction—achieving a longtime, elusive goal that could lead to therapies preventing ...

page 1 from 4